Not recruiting yet
Robot Assisted Minimally Invasive Treatment Versus Conservative Treatment for Fragility Fractures of the Pelvis Type 1-2 in Elderly Patients
NCT07636616 · Junbo Liang · Updated 9 June 2026
- What is being tested
- Robot Assisted Minimally Invasive Fixation
- For
- Fragility Fractures of the Pelvis (FFP)
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 60 years and older. About 152 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 1 June 2026, ends 30 Dec 2028. Registered 9 June 2026.
- Results
- None posted yet.
In the researchers' words
This prospective randomized controlled trial aims to compare the efficacy and safety of robot assisted minimally invasive treatment versus conservative treatment in elderly patients with FFP1-2 fragility fractures of the pelvis. Eligible patients will be stratified according to FFP classification and randomly assigned in a 1:1 ratio to receive either robot assisted minimally invasive fixation or standardized conservative treatment. Primary and secondary outcomes include pain relief, functional recovery, fracture progression, venous thromboembolism events, complications, and healthcare resource utilization. The study aims to provide evidence for optimizing treatment strategies in elderly patients with pelvic fragility fractures.